Fabrizio De Ponti
Università degli Studi di Bologna
H-index: 62
Europe-Italy
Top articles of Fabrizio De Ponti
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Using artificial intelligence to create diverse and inclusive medical case vignettes for education | British journal of clinical pharmacology | Michiel J Bakkum Mariëlle G Hartjes Joost D Piët Erik M Donker Robert Likic | 2024/1/6 |
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System | Targeted Oncology | Sara Cecco Stefano Puligheddu Michele Fusaroli Lorenzo Gerratana Miao Yan | 2024/5/2 |
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward | British Journal of Clinical Pharmacology | Elisabetta Poluzzi Emanuel Raschi Carlotta Lunghi Alice Bertuccio Andreas Eleftheriou | 2024/3/22 |
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis | Drug Safety | Emanuel Raschi Francesco Salvo Andrew Bate Fabrizio De Ponti Elisabetta Poluzzi | 2024/3/18 |
The European list of key medicines for medical education: a modified Delphi study | Clinical Pharmacology & Therapeutics | Erik M Donker Pietro Spitaleri Timpone David J Brinkman Milan C Richir Paraskevi Papaioannidou | 2024/3 |
Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study | Psychiatry and Clinical Neurosciences | Michele Fusaroli Valentina Giunchi Vera Battini Michele Gringeri Roberto Rimondini | 2023/3 |
A clinical pharmacology and therapeutics Teacher's guide to race‐based medicine, inclusivity, and diversity | Michiel J Bakkum Petra Verdonk Elias G Thomas Floor van Rosse Michael Okorie | 2023/3 | |
Authors’ Reply to Cappello et al. Comment on:“Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration … | Drug safety | Michele Fusaroli Guido Pelletti Valentina Giunchi Emanuel Raschi Fabrizio De Ponti | 2023/9 |
Unveiling the Hidden Toll of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System. | medRxiv | Michele Fusaroli Stefano Polizzi Luca Menestrina Valentina Giunchi Luca Pellegrini | 2023 |
Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice | British Journal of Clinical Pharmacology | Emanuel Raschi Elisabetta Poluzzi Fabrizio De Ponti | 2023/8 |
Antipsychotics and drug-induced liver injury: toward minimum requirements in reporting pharmacovigilance studies | Journal of Clinical Psychopharmacology | Emanuel Raschi Georgios Schoretsanitis Chiara Gastaldon Charles Khouri Francesco Salvo | 2023/1/1 |
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project | European journal of clinical pharmacology | Michiel J Bakkum Erik M Donker Pietro Spitaleri Timpone Charlotte AM Hagen Milan C Richir | 2023/4 |
Deliberate self-poisoning: real-time characterization of suicidal habits and toxidromes in the food and drug administration adverse event reporting system | Drug safety | Michele Fusaroli Guido Pelletti Valentina Giunchi Chiara Pugliese Mattia Bartolucci | 2023/3 |
Skin toxicities with cyclin-dependent kinase 4/6 inhibitors in breast cancer: signals from disproportionality analysis of the FDA adverse event reporting system | American Journal of Clinical Dermatology | Emanuel Raschi Michele Fusaroli Michelangelo La Placa Andrea Ardizzoni Claudio Zamagni | 2022/3/1 |
Amyotrophic lateral sclerosis as an adverse drug reaction: a disproportionality analysis of the food and drug administration adverse event reporting system | Drug Safety | Anna Gaimari Michele Fusaroli Emanuel Raschi Elisa Baldin Luca Vignatelli | 2022/6 |
Safety of Bempedoic Acid: Post-marketing Analysis of the FDA Adverse Event Reporting System | Drug Safety | E Raschi M Fusaroli M Forni A Goldman AFG Cicero | 2022/10/1 |
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction | Emanuel Raschi Igor Diemberger Mario Sabatino Elisabetta Poluzzi Fabrizio De Ponti | 2022/2/11 | |
The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely | European Journal of Clinical Pharmacology | Erik M Donker David J Brinkman Milan C Richir Paraskevi Papaioannidou Robert Likic | 2022/6 |
Hyperacute Multisystem Toxicities with Immune Checkpoint Inhibitors in the FDA Adverse Event Reporting System: The Immune-Adversome | Drug Safety | E Raschi V Giunchi M Fusaroli A Ardizzoni E Poluzzi | 2022/10/1 |
Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants | Pediatric Research | Silvia Martini Francesca Vitali Irene Capelli Chiara Donadei Emanuel Raschi | 2022/6 |
Co-Authors
